MYO · AMEX · Medical - Devices

Myomo

Custom powered arm-and-hand braces controlled by remaining muscle signals.

$1.57
After-hours close−0.03 (−2.18%)
At close$1.61(−3.31%)
Loading prices…

Profile

Myomo, Inc.MYOHealth Care

Sells custom-built powered MyoPro braces that interpret users’ remaining muscle signals to assist weakened or partially paralyzed arms and hands. Revenue combines direct insurer billing with wholesale sales to O&P practices, VA providers, and international accounts, making reimbursement authorization and delivery central to the business.

Designs and custom-fabricates the MyoPro platform, a powered arm-and-hand brace for people with upper-limb weakness or paralysis. Surface sensors interpret remaining muscle signals, then software and motors assist elbow and hand movement. The platform includes Motion W, Motion G, MyoCare training and support, MyoGames practice, MARK2 clinical evaluation, and a connected-care application.

Sells mainly through direct billing, alongside O&P practices, Veterans Health Administration providers, and international distributors. The United States is its principal market and Germany its only individually material foreign market. Its clinical operation evaluates patients, secures insurance authorization, customizes and fits the brace, trains users, and provides follow-up. Revenue timing depends on authorization, delivery, and payer adjudication; the business relies on a single product family, reimbursement coverage, regulated manufacturing, and specialized suppliers.

Company facts

CEOPaul R. Gudonis
ListedJun 12, 2017
ExchangeAMEX
HeadquartersBurlington, MA
CountryUnited States
Employees195
CIK0001369290
ISINUS62857J2015

Key statistics

Market cap$61.8M
EPS (ttm)−$0.3404
P/E (ttm)−4.70
ROE-142.0%
P/B11.72
P/S1.43
Dividend yield
Beta1.97vs XLV 0.28

Year to date +62.1% · Average volume (30d) 642.5K

Analysts

Price target, next 12 months$1.10−31.3%Median of 8 analysts · vs the Aug 28 close
ConsensusBuy7 of 8 analysts rate it buy or better

Ratings

Target range

Latest analyst notes

No analyst notes in the last 24 months.

Earnings

EPS

Estimate−$0.09
ReportedDue Nov 9, 2026

Revenue

Estimate$11.5M
ReportedDue Nov 9, 2026

History

Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseNext session
Aug 5, 2026Q2 FY26−$0.10−$0.07+28.6%$10.4M$11.7M+13.1%+23.58%
May 7, 2026Q1 FY26−$0.12−$0.09+25.0%$9.2M$10.1M+9.5%−5.05%
Mar 9, 2026Q4 FY25−$0.09−$0.08+11.1%$10.4M$11.4M+9.1%−16.80%
Nov 10, 2025Q3 FY25−$0.11−$0.09+18.2%$10.4M$10.1M−3.0%−7.31%
View details

Financial highlights

11 quartersQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$9.8M$9.7M$10.1M$11.4M$10.1M$11.7M
Gross profit$6.6M$6.1M$6.4M$7.8M$6.9M$8.4M
Operating income−$3.5M−$4.6M−$3.5M−$2.8M−$3.2M−$2.3M
Net income−$3.5M−$4.6M−$3.7M−$3.8M−$3.0M−$4.0M
Diluted EPS−$0.08−$0.11−$0.09−$0.09−$0.07−$0.09
Gross margin67.2%62.7%63.8%68.6%68.2%72.1%
Operating margin-35.8%-47.6%-34.9%-24.4%-31.2%-19.3%

Fiscal years (4-quarter sums)FY24 $32.6M · FY25 $40.9M

Revenue by product · FY24

Product$32.6M · 100%

Balance sheet, Jun 30, 2026Cash & short-term investments $13.5M · Total debt $20.1M · Total assets $35.3M · Shareholders' equity $5.8M

Dividends

No dividends on record.

Ownership

Institutions 33.12%12.80M sharesInsiders 5.54%2.14M sharesOther 61.34%23.70M shares

Shares outstanding 38.64M · Float 35.18M · 91.0% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
Rosalind Advisors, Inc.3.85M9.96%13FMay 14, 2026
Horton Capital Partners, LLC2.31M6.00%13DMay 18, 2026
BlackRock, Inc.1.69M4.37%13FMay 13, 2026
Paul R. Gudonis · director, officer: Chief Executive Officer1.43M3.71%Form 4Aug 11, 2026
Vanguard Capital Management LLC1.14M2.96%13FMay 15, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Aug 20, 2026Harry Kovelmanofficer: Chief Medical Officer−34,750$1.73
View details

Peers

  • Mobia Medical

    Stroke-recovery pathway rival for chronic upper-limb impairment.

  • Lifeward

    Emerging powered upper-body orthosis challenger in stroke care.

CompareAfter-hours close

CompanyPriceChange
Myomo$1.57−2.18%$61.8M1.4+21.3%
Mobia Medical$11.34−0.35%$377.0M14.7
Lifeward$7.47+0.13%$12.0M0.6+15.7%
Median7.6+15.7%